Hiperemesis Gravidarum

01Pathophysiology

Hyperemesis gravidarum represents the severe end of the nausea-vomiting spectrum in pregnancy. While up to 80% of pregnant women experience some degree of nausea during the first trimester, hyperemesis gravidarum is defined by persistent vomiting leading to dehydration, ketonuria, and weight loss exceeding 5% of pre-pregnancy body weight. The condition typically peaks between weeks 8 and 12, correlating with the peak of serum beta-hCG.

The central driver is beta-hCG, which structurally resembles TSH and acts on the chemoreceptor trigger zone in the area postrema. This explains two important exam-relevant phenomena. First, conditions that produce abnormally high hCG levels (molar pregnancy, multiple gestations) carry a higher risk of hyperemesis. Second, the structural homology between hCG and TSH means that very high hCG levels can cross-stimulate the TSH receptor on thyroid follicular cells, producing a state called gestational transient thyrotoxicosis. This results in a suppressed TSH and mildly elevated free T4 without true hyperthyroidism. This is a self-limited condition that does not require antithyroid treatment, and distinguishing it from Graves disease is a classic exam trap.

The relentless vomiting leads to loss of gastric hydrochloric acid, producing the hallmark electrolyte pattern: hypochloremic hypokalemic metabolic alkalosis. Chloride and hydrogen ions are lost directly in the vomitus. The kidney compensates by retaining hydrogen ions at the expense of potassium, worsening hypokalemia. Severe volume depletion triggers an aldosterone response that further drives potassium wasting.

A critical downstream complication arises from thiamine (vitamin B1) depletion. Prolonged inability to eat depletes thiamine stores, and if dextrose-containing IV fluids are administered before thiamine repletion, the glucose load accelerates thiamine consumption in glycolysis, precipitating Wernicke encephalopathy (confusion, ophthalmoplegia, ataxia). This is the single most dangerous and most testable complication of hyperemesis gravidarum.

02Classification and Clinical Manifestation

The key clinical discriminator between normal pregnancy-related nausea and hyperemesis gravidarum is the presence of weight loss, ketonuria, and inability to maintain hydration through oral intake. Exam vignettes will emphasize these features to signal that the patient has crossed from physiologic nausea into a pathologic state requiring intervention.

It is also worth noting the typical timeline. Symptoms that begin after 10 to 12 weeks, or that persist well into the second trimester, should raise concern for alternative diagnoses such as gastroparesis, biliary disease, pancreatitis, or a CNS lesion.

03Diagnostic Workup

Urinalysis is the best initial test because it is rapid, noninvasive, and immediately confirms two hallmarks of the diagnosis: ketonuria (indicating starvation physiology) and concentrated urine (indicating dehydration). A urine dipstick positive for ketones in a first-trimester pregnant woman with persistent vomiting and weight loss essentially clinches the clinical diagnosis.

The basic metabolic panel follows to guide fluid and electrolyte management. The classic pattern of low chloride, low potassium, and elevated bicarbonate reflects the metabolic alkalosis from gastric acid loss. A prerenal pattern (BUN-to-creatinine ratio >20:1) confirms volume depletion.

Thyroid function tests are important to order early, not because you expect true thyroid disease, but because the suppressed TSH is a predictable finding in hyperemesis and should not trigger unnecessary antithyroid therapy. The distinguishing features from Graves disease include: absence of thyroid antibodies (anti-TSH receptor antibody/TSI), absence of goiter or ophthalmopathy, and spontaneous resolution as hCG levels decline after the first trimester.

Pelvic ultrasound is ordered to confirm the pregnancy and, critically, to rule out a molar pregnancy. If a patient presents with hyperemesis gravidarum and a uterus that is large for gestational age with a "snowstorm" pattern on ultrasound, the underlying cause is gestational trophoblastic disease, which changes management entirely.

There is no single "gold standard" confirmatory test for hyperemesis gravidarum. It is a clinical diagnosis based on the triad of intractable vomiting, weight loss exceeding 5%, and ketonuria in the context of early pregnancy, after exclusion of other causes.

04Management and Treatment

Acute stabilization begins with aggressive IV hydration. Normal saline is preferred because it directly replaces the chloride lost in vomiting and corrects the metabolic alkalosis. Potassium repletion is added once urine output is confirmed adequate.

The single most important management pearl is the sequencing of thiamine before dextrose. This is tested repeatedly. Thiamine is a cofactor for pyruvate dehydrogenase and transketolase. When dextrose is infused into a thiamine-depleted patient, the sudden glycolytic load exhausts remaining thiamine stores, triggering acute Wernicke encephalopathy. The correct sequence is always: thiamine first, then dextrose.

For outpatient management of milder presentations, the pyridoxine-doxylamine combination is first-line. Pyridoxine (vitamin B6) is given at 10 to 25 mg three times daily, and if insufficient, doxylamine (an antihistamine with antiemetic properties) is added. This combination has the longest safety track record in pregnancy.

When patients fail oral therapy and require hospitalization, ondansetron becomes the most commonly tested first-line parenteral antiemetic. It is a serotonin 5-HT3 receptor antagonist that acts on the chemoreceptor trigger zone. There has been some concern about a small risk of cleft palate with first-trimester use, but current guidelines consider it acceptable when benefits outweigh risks.

Corticosteroids are reserved for truly refractory cases. Methylprednisolone should not be used before 10 weeks of gestation due to an association with oral clefts. The mechanism is thought to involve suppression of the immune and inflammatory pathways that may contribute to the nausea cascade.

Electrolyte correction should be gradual. Rapid correction of hyponatremia, if present, risks osmotic demyelination syndrome (central pontine myelinolysis). Sodium should not be corrected faster than 8 to 10 mEq/L per 24 hours.

05Differential Diagnosis and Distractors

The most dangerous distractor on the exam is molar pregnancy, because it can present identically to hyperemesis gravidarum. A vignette with a first-trimester patient who has intractable vomiting, a uterus larger than expected, and an extremely high hCG should prompt you to select molar pregnancy (or at least pelvic ultrasound as the next step) rather than simply treating hyperemesis.

The Graves disease versus gestational transient thyrotoxicosis distinction is tested as a "do not treat" question. The correct answer is observation, not methimazole or propylthiouracil, when the thyroid abnormality is in the context of hyperemesis with no antibodies and no eye findings.

06Traps and High-Yield Pearls

The single most tested trap in hyperemesis gravidarum is the thiamine-before-dextrose rule. A vignette will describe a dehydrated, vomiting pregnant woman and ask for the next best step. The temptation is to order D5 normal saline immediately for both hydration and caloric support. The correct answer is to give thiamine first. Administering glucose to a thiamine-depleted patient precipitates Wernicke encephalopathy, a devastating and preventable complication. If the question stem mentions any neurologic symptom (confusion, gaze palsy, ataxia) in a patient with prolonged hyperemesis, you are being tested on whether you recognize iatrogenic Wernicke encephalopathy from premature dextrose administration.

The second major trap is mistaking gestational transient thyrotoxicosis for Graves disease. Both show low TSH and elevated free T4, but the appropriate management in the context of hyperemesis is reassurance and supportive care. Initiating antithyroid drugs in this scenario is a wrong answer designed to catch students who reflexively treat every abnormal TSH.

A third pearl involves the electrolyte pattern. If a vignette gives you a pregnant woman with vomiting and asks you to predict the electrolyte abnormality, the answer is hypochloremic hypokalemic metabolic alkalosis. If the patient instead has metabolic acidosis with an anion gap, the diagnosis is not hyperemesis but rather diabetic ketoacidosis or another acidosis-producing condition.

Finally, always check the gestational age and uterine size in the vignette. Hyperemesis peaks at 8 to 12 weeks and typically resolves by 20 weeks. If the uterine size is discordant (larger than expected for dates), suspect molar pregnancy or multiple gestation as the underlying driver. The core competency being tested across all these scenarios is your ability to sequence the workup and treatment correctly, recognize when a common diagnosis is masking a more dangerous one, and avoid initiating unnecessary or harmful therapies based on laboratory findings taken out of clinical context.